{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:34:37Z","timestamp":1792290877699,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03717-5","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T19:03:31Z","timestamp":1728587011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-6985","authenticated-orcid":false,"given":"Bruno Nogueira","family":"Cesar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-4379","authenticated-orcid":false,"given":"Walter Moises Tobias","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-5310","authenticated-orcid":false,"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1341-5697","authenticated-orcid":false,"given":"Marcelino de Souza Dur\u00e3o","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"1","key":"3717_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3717_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3717_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10428190601126602","volume":"48","author":"V Eleutherakis-Papaiakovou","year":"2007","unstructured":"Eleutherakis-Papaiakovou V, Bamias A, Gika D, Simeonidis A, Pouli A, Anagnostopoulos A, et al. Renal failure in multiple myeloma: incidence, correlations, and prognostic significance. Leuk Lymphoma. 2007;48(2):337\u201341.","journal-title":"Leuk Lymphoma"},{"key":"3717_CR4","doi-asserted-by":"crossref","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21\u201333.","DOI":"10.4065\/78.1.21"},{"issue":"25","key":"3717_CR5","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","volume":"116","author":"AJ Waxman","year":"2010","unstructured":"Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116(25):5501\u20136.","journal-title":"Blood"},{"issue":"13","key":"3717_CR6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E, et al. International Myeloma Working Group Recommendations for the diagnosis and management of Myeloma-related renal impairment. J Clin Oncol. 2016;34(13):1544\u201357.","journal-title":"J Clin Oncol"},{"key":"3717_CR7","doi-asserted-by":"publisher","first-page":"487285","DOI":"10.1155\/2013\/487285","volume":"2013","author":"D Katagiri","year":"2013","unstructured":"Katagiri D, Noiri E, Hinoshita F. Multiple myeloma and kidney disease. ScientificWorldJournal. 2013;2013:487285.","journal-title":"ScientificWorldJournal"},{"issue":"2","key":"3717_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40620-018-0492-4","volume":"32","author":"IJ Sathick","year":"2019","unstructured":"Sathick IJ, Drosou ME, Leung N. Myeloma light chain cast nephropathy, a review. J Nephrol. 2019;32(2):189\u201398.","journal-title":"J Nephrol"},{"issue":"2","key":"3717_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ajh.21922","volume":"86","author":"UD Bayraktar","year":"2011","unstructured":"Bayraktar UD, Warsch S, Pereira D. High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma. Am J Hematol. 2011;86(2):224\u20137.","journal-title":"Am J Hematol"},{"issue":"4","key":"3717_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3324\/haematol.10759","volume":"92","author":"E Kastritis","year":"2007","unstructured":"Kastritis E, Anagnostopoulos A, Roussou M, Gika D, Matsouka C, Barmparousi D, et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Haematologica. 2007;92(4):546\u20139.","journal-title":"Haematologica"},{"issue":"36","key":"3717_CR11","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1200\/JCO.2009.22.2232","volume":"27","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Richardson PG, Schlag R, Khuageva NK, Shpilberg O, Kastritis E, et al. VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study. J Clin Oncol. 2009;27(36):6086\u201393.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3717_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/leu.2012.182","volume":"27","author":"MA Dimopoulos","year":"2013","unstructured":"Dimopoulos MA, Roussou M, Gkotzamanidou M, Nikitas N, Psimenou E, Mparmparoussi D, et al. The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma. Leukemia. 2013;27(2):423\u20139.","journal-title":"Leukemia"},{"issue":"30","key":"3717_CR13","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1200\/JCO.2010.28.1238","volume":"28","author":"H Ludwig","year":"2010","unstructured":"Ludwig H, Adam Z, Hajek R, Greil R, Tothova E, Keil F, et al. Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study. J Clin Oncol. 2010;28(30):4635\u201341.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3717_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0609.2009.01385.x","volume":"84","author":"F Morabito","year":"2010","unstructured":"Morabito F, Gentile M, Ciolli S, Petrucci MT, Galimberti S, Mele G, et al. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA. Eur J Haematol. 2010;84(3):223\u20138.","journal-title":"Eur J Haematol"},{"issue":"5","key":"3717_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ajh.24335","volume":"91","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Roussou M, Gavriatopoulou M, Psimenou E, Eleutherakis-Papaiakovou E, Migkou M, et al. Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis. Am J Hematol. 2016;91(5):499\u2013502.","journal-title":"Am J Hematol"},{"issue":"8","key":"3717_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.bmt.1704440","volume":"33","author":"CK Lee","year":"2004","unstructured":"Lee CK, Zangari M, Barlogie B, Fassas A, van Rhee F, Thertulien R, et al. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant. Bone Marrow Transpl. 2004;33(8):823\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"3717_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.bbmt.2009.03.021","volume":"15","author":"GC Parikh","year":"2009","unstructured":"Parikh GC, Amjad AI, Saliba RM, Kazmi SM, Khan ZU, Lahoti A, et al. Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. Biol Blood Marrow Transpl. 2009;15(7):812\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"3717_CR18","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/ckj\/sfaa220","volume":"14","author":"B Tarragon","year":"2021","unstructured":"Tarragon B, Ye N, Gallagher M, Sen S, Portoles JM, Wang AY. Effect of high cut-off dialysis for acute kidney injury secondary to cast nephropathy in patients with multiple myeloma: a systematic review and meta-analysis. Clin Kidney J. 2021;14(8):1894\u2013900.","journal-title":"Clin Kidney J"},{"issue":"11","key":"3717_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ki.2008.108","volume":"73","author":"N Leung","year":"2008","unstructured":"Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008;73(11):1282\u20138.","journal-title":"Kidney Int"},{"issue":"24","key":"3717_CR20","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1056\/NEJMc1101834","volume":"364","author":"BL Burnette","year":"2011","unstructured":"Burnette BL, Leung N, Rajkumar SV. Renal improvement in myeloma with bortezomib plus plasma exchange. N Engl J Med. 2011;364(24):2365\u20136.","journal-title":"N Engl J Med"},{"issue":"8","key":"3717_CR21","first-page":"4299","volume":"34","author":"S Park","year":"2014","unstructured":"Park S, Han B, Kim K, Kim SJ, Jang JH, Kim WS, et al. Renal insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement. Anticancer Res. 2014;34(8):4299\u2013306.","journal-title":"Anticancer Res"},{"issue":"1","key":"3717_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/s12885-018-4926-0","volume":"18","author":"M Antlanger","year":"2018","unstructured":"Antlanger M, Dust T, Reiter T, Bohm A, Lamm WW, Gornicec M, et al. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer. 2018;18(1):1008.","journal-title":"BMC Cancer"},{"issue":"5","key":"3717_CR23","doi-asserted-by":"publisher","first-page":"e22888","DOI":"10.1002\/jcla.22888","volume":"33","author":"J Chen","year":"2019","unstructured":"Chen J, Liu H, Li L, Liu Z, Song J, Wang G, et al. Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function. J Clin Lab Anal. 2019;33(5):e22888.","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"3717_CR24","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/j.clml.2019.05.010","volume":"19","author":"PJ Ho","year":"2019","unstructured":"Ho PJ, Moore EM, McQuilten ZK, Wellard C, Bergin K, Augustson B, et al. Renal impairment at diagnosis in Myeloma: patient characteristics, treatment, and impact on outcomes. Results from the Australia and New Zealand Myeloma and related diseases Registry. Clin Lymphoma Myeloma Leuk. 2019;19(8):e415\u201324.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"3717_CR25","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","volume":"79","author":"WC Faquin","year":"1992","unstructured":"Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood. 1992;79(8):1987\u201394.","journal-title":"Blood"},{"issue":"7","key":"3717_CR26","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","volume":"80","author":"RT Means Jr","year":"1992","unstructured":"Means RT Jr., Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood. 1992;80(7):1639\u201347.","journal-title":"Blood"},{"issue":"4","key":"3717_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2141.1992.tb06939.x","volume":"82","author":"Y Beguin","year":"1992","unstructured":"Beguin Y, Yerna M, Loo M, Weber M, Fillet G. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br J Haematol. 1992;82(4):648\u201353.","journal-title":"Br J Haematol"},{"issue":"2","key":"3717_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12630-012-9861-y","volume":"60","author":"GM Hare","year":"2013","unstructured":"Hare GM, Freedman J, David Mazer C. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety? Can J Anaesth. 2013;60(2):168\u201375.","journal-title":"Can J Anaesth"},{"issue":"2","key":"3717_CR29","doi-asserted-by":"publisher","first-page":"e55870","DOI":"10.1371\/journal.pone.0055870","volume":"8","author":"E Canet","year":"2013","unstructured":"Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D, et al. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS ONE. 2013;8(2):e55870.","journal-title":"PLoS ONE"},{"issue":"9","key":"3717_CR30","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transpl. 2013;28(9):2221\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"3\u20134","key":"3717_CR31","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1159\/000345509","volume":"121","author":"LG Sanchez-Lozada","year":"2012","unstructured":"Sanchez-Lozada LG, Lanaspa MA, Cristobal-Garcia M, Garcia-Arroyo F, Soto V, Cruz-Robles D, et al. Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol. 2012;121(3\u20134):e71\u20138.","journal-title":"Nephron Exp Nephrol"},{"issue":"6","key":"3717_CR32","doi-asserted-by":"publisher","first-page":"F730","DOI":"10.1152\/ajprenal.00520.2011","volume":"302","author":"MM Rabadi","year":"2012","unstructured":"Rabadi MM, Kuo MC, Ghaly T, Rabadi SM, Weber M, Goligorsky MS, et al. Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Ren Physiol. 2012;302(6):F730\u201341.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"3717_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269\u201375.","journal-title":"J Hypertens"},{"issue":"5","key":"3717_CR34","doi-asserted-by":"publisher","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","volume":"304","author":"ES Ryu","year":"2013","unstructured":"Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, et al. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Ren Physiol. 2013;304(5):F471\u201380.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"12","key":"3717_CR35","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.2215\/CJN.02980316","volume":"11","author":"SS Motwani","year":"2016","unstructured":"Motwani SS, Herlitz L, Monga D, Jhaveri KD, Lam AQ. American Society of Nephrology Onco-Nephrology F. Paraprotein-related kidney disease: Glomerular Diseases Associated with Paraproteinemias. Clin J Am Soc Nephrol. 2016;11(12):2260\u201372.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"3717_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1600-0609.1994.tb00190.x","volume":"53","author":"LM Knudsen","year":"1994","unstructured":"Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J. Renal function in newly diagnosed multiple myeloma\u2013a demographic study of 1353 patients. The nordic Myeloma Study Group. Eur J Haematol. 1994;53(4):207\u201312.","journal-title":"Eur J Haematol"},{"issue":"2","key":"3717_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11899-020-00568-3","volume":"15","author":"MH Jagosky","year":"2020","unstructured":"Jagosky MH, Usmani SZ. Extramedullary Disease in multiple myeloma. Curr Hematol Malig Rep. 2020;15(2):62\u201371.","journal-title":"Curr Hematol Malig Rep"},{"issue":"11","key":"3717_CR38","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","volume":"97","author":"SZ Usmani","year":"2012","unstructured":"Usmani SZ, Heuck C, Mitchell A, Szymonifka J, Nair B, Hoering A, et al. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica. 2012;97(11):1761\u20137.","journal-title":"Haematologica"},{"issue":"5","key":"3717_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clml.2014.12.013","volume":"15","author":"S Deng","year":"2015","unstructured":"Deng S, Xu Y, An G, Sui W, Zou D, Zhao Y, et al. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases. Clin Lymphoma Myeloma Leuk. 2015;15(5):286\u201391.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"3717_CR40","first-page":"890","volume":"103","author":"N Gagelmann","year":"2018","unstructured":"Gagelmann N, Eikema DJ, Iacobelli S, Koster L, Nahi H, Stoppa AM, et al. Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the chronic malignancies Working Party of the EBMT. Haematologica. 2018;103(5):890\u20137.","journal-title":"Haematologica"},{"issue":"36","key":"3717_CR41","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","volume":"23","author":"BM Augustson","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002\u2013Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23(36):9219\u201326.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3717_CR42","doi-asserted-by":"publisher","first-page":"e23416","DOI":"10.1002\/jcla.23416","volume":"34","author":"X Chen","year":"2020","unstructured":"Chen X, Luo X, Zu Y, Issa HA, Li L, Ye H, et al. Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients. J Clin Lab Anal. 2020;34(9):e23416.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"3717_CR43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/ndt\/gfz211","volume":"36","author":"M Courant","year":"2021","unstructured":"Courant M, Orazio S, Monnereau A, Preterre J, Combe C, Rigothier C. Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry. Nephrol Dial Transpl. 2021;36(3):482\u201390.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3717_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1046\/j.1365-2141.2001.03033.x","volume":"114","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C, Zangari M, et al. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol. 2001;114(4):822\u20139.","journal-title":"Br J Haematol"},{"issue":"6","key":"3717_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41409-022-01657-y","volume":"57","author":"I Lazana","year":"2022","unstructured":"Lazana I, Floro L, Christmas T, Shah S, Bramham K, Cuthill K, et al. Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option. Bone Marrow Transpl. 2022;57(6):959\u201365.","journal-title":"Bone Marrow Transpl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03717-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03717-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03717-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:04:34Z","timestamp":1728644674000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03717-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03717-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4249652\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics in Research Committee of the Federal University of S\u00e3o Paulo (protocol number 0573\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"It was a study mainly based on medical records. We tried to contact all patients to obtain their consent for the data to be used. However, the telephone numbers and addresses in the registries were not valid anymore for most older cases. Informed consent was obtained from the patients we were able to contact directly. All records were anonymized before analysis. The waiver of informed consent for ancient patients that we have not been able to contact has been approved by the ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}